XOMA Royalty Corp

XOMANasdaq· Pharmaceutical Preparations

Price History

Revenue

$10.3M

▲ 55.6% YoY

Net Income

$31.7M

▲ 329.4% YoY

EPS

$1.46

▲ 188.5% YoY

Cash

$82.9M

▼ 18.4% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.